HP-211
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HP-211, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes [Phase 2]